Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve Pubget Overpricing |
lüll Multiple sclerosis: what have we learned from magnetic resonance imaging studies?Khoury SJ; Weiner HLArch Intern Med 1998[Mar]; 158 (6): 565-73We review studies that have examined the relationship between magnetic resonance imaging findings and clinical disability, postmortem observations, and cognitive dysfunction in patients with multiple sclerosis. We also review the use of magnetic resonance imaging findings as an outcome measure in clinical trials assessing the efficacy of new therapeutic agents for the treatment of multiple sclerosis. More advanced applications of magnetic resonance imaging and their use in multiple sclerosis is addressed later in the article.|*Magnetic Resonance Imaging[MESH]|Adjuvants, Immunologic/therapeutic use[MESH]|Clinical Trials as Topic[MESH]|Cognition[MESH]|Cyclosporine/therapeutic use[MESH]|Gadolinium DTPA[MESH]|Humans[MESH]|Immunosuppressive Agents/therapeutic use[MESH]|Interferon beta-1a[MESH]|Interferon beta-1b[MESH]|Interferon-alpha/therapeutic use[MESH]|Interferon-beta/therapeutic use[MESH]|Multiple Sclerosis/drug therapy/*pathology/*physiopathology[MESH]|Prognosis[MESH]|Psychomotor Performance[MESH]|Severity of Illness Index[MESH]|Treatment Outcome[MESH] |